A Cleveland Clinic study published January 27, 2025, indicates that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications compared with patients who received medical therapy alone. The study results were published in Nature Medicine journal.
Key clip from the Cleveland Clinic press release—
“Ali Aminian, M.D., director of Cleveland Clinic’s Bariatric & Metabolic Institute and lead investigator of the study, said results show that bariatric surgery should be considered as a treatment option in patients with cirrhosis and obesity. ‘Bariatric surgery was associated with a 72% lower risk of developing serious complications of liver disease and an 80% lower risk of progression to decompensated stage among patients with compensated cirrhosis and obesity.'”
